These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22931519)

  • 1. Developing new drugs for diabetes and cardiometabolic disorders: a changing paradigm.
    Krentz AJ; Morrow L; Hompesch M
    Drugs; 2012 Sep; 72(13):1709-11. PubMed ID: 22931519
    [No Abstract]   [Full Text] [Related]  

  • 2. Could clinical inertia in part explain the unexpected association of insulin therapy with poorer cardiovascular outcomes in observational studies on diabetes?
    Giorda CB
    Diabetes Res Clin Pract; 2011 Jun; 92(3):e47-8. PubMed ID: 21035888
    [No Abstract]   [Full Text] [Related]  

  • 3. The FDA and hypoglycemic drugs.
    Davidson JK
    JAMA; 1975 May; 232(8):853-5. PubMed ID: 1091764
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular safety and diabetes drug development.
    Drucker DJ; Goldfine AB
    Lancet; 2011 Mar; 377(9770):977-9. PubMed ID: 21316097
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes management: More than just cardiovascular risk?
    Zimmerman RS; Pantalone KM
    Cleve Clin J Med; 2014 Nov; 81(11):672-6. PubMed ID: 25368217
    [No Abstract]   [Full Text] [Related]  

  • 6. [Increased risk of cardiovascular complications with oral hypoglycemic agents?].
    Mueller R
    Acta Diabetol Lat; 1970; 7(5):805-23. PubMed ID: 4949515
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular safety trials: be careful what you wish for.
    Bloomgarden Z; Grunberger G
    J Diabetes; 2014 Jan; 6(1):1-3. PubMed ID: 24103189
    [No Abstract]   [Full Text] [Related]  

  • 8. [The trend of new drug development for the treatment of diabetes mellitus].
    Kaku K
    Nihon Rinsho; 2015 Dec; 73(12):2108-14. PubMed ID: 26666161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Protection in People With Diabetes.
    ; Stone JA; Houlden RL; Lin P; Udell JA; Verma S
    Can J Diabetes; 2018 Apr; 42 Suppl 1():S162-S169. PubMed ID: 29650091
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular effects of current and future anti-obesity drugs.
    Comerma-Steffensen S; Grann M; Andersen CU; Rungby J; Simonsen U
    Curr Vasc Pharmacol; 2014 May; 12(3):493-504. PubMed ID: 24846238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Settling the UGDP controversy"?
    Bradley RF; Dolger H; Forsham PH; Seltzer H
    JAMA; 1975 May; 232(8):813-7. PubMed ID: 1091759
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiologists and the management of blood sugar: a Chinese perspective.
    Hu DY; Guo YF
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):509. PubMed ID: 18719711
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rehabilitation of oral hypoglycemic agents].
    Biron P
    Union Med Can; 1975 Sep; 104(9):1421-4. PubMed ID: 1179546
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies for the development of new PPAR agonists in diabetes.
    Cavender MA; Nicholls SJ; Lincoff AM
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S32-7. PubMed ID: 20489419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin: a multitasking medication.
    Bailey CJ
    Diab Vasc Dis Res; 2008 Sep; 5(3):156. PubMed ID: 18777487
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
    Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
    Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of the side effects of oral hypoglycemic agents in diabetes mellitus].
    Ishii J; Suzuki M
    Nihon Rinsho; 1990 Dec; 48 Suppl():955-61. PubMed ID: 2086978
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral hypoglycaemic agents.
    Hadden DR
    Ir J Med Sci; 1973 May; 142(3 Suppl):11-7. PubMed ID: 4723012
    [No Abstract]   [Full Text] [Related]  

  • 19. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
    JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for the Presence of Cardiovascular Disease.
    ; Poirier P; Bertrand OF; Leipsic J; Mancini GBJ; Raggi P; Roussin A
    Can J Diabetes; 2018 Apr; 42 Suppl 1():S170-S177. PubMed ID: 29650092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.